NURSING PRACTICE GUIDELINES

Similar documents
CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

4.0 Definitions. Subcutaneous: is defined as the loose connective tissue between the epidermis and the muscle.

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

Insertion and Monitoring of Intravenous and Subcutaneous Cannula and Infusions: Standard Operating Procedures

SPAGG. Coversheet for Specialist Palliative Audit and Guideline Group Agreed Documentation

ASSESSMENT AND CARE Monitor for the following and remove catheter if there is: redness, pain, swelling, firm tissue, exudates, bleeding or leakage.

Appendix E: Overview of Vascular

NOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline. P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath).

Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings

Parenteral Products. By: Howida Kamal, Ph.D

Curraheen, Co. Cork. Guidelines on the Management and Care of Central Venous Access Devices

Subcutaneous (SQ) Hydration Augmented by Hyaluronidase

SFHCHS22 - SQA Code HD16 04 Perform intravenous cannulation

Presentation Menu. Walk-in Slide. Full Presentation. Access. Site. Needle. Flush. Comfort. Monitor. Removing the EZ-IO catheter.

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

SCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS

Guidelines for the Care and Maintenance of Intravenous Access Devices in Paediatric Patients

USE OF MCKINLEY T34 SYRINGE DRIVER

Successful IV Starts Revised February 2014

IV Fluids. Nursing B23. Objectives. Serum Osmolality

Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE

Unit 11. Objectives. Indications for IV Therapy. Intravenous Access Devices & Common IV Fluids. 3 categories. Maintenance Replacement Restoration

Ig Therapy: One Size Does Not Fit All

IV Link Staff. Infection Prevention & Control A Learning Package for IV Link Staff

Patient Information Publications Warren Grant Magnuson Clinical Center National Institutes of Health

PATIENT CARE PLAN FOR CARE OF PERIPHERAL MIDLINE. Manufacturers specific recommendations should be noted and adhered to by individual practitioners.

CENTRAL VENOUS ACCESS DEVICES. BETHANY COLTON

Taking nose, throat and skin swabs. Clinical Skills

Chapter 64 Administration of Injectable Medications

PAEDIATRIC NERVE BLOCK / WOUND INFILTRATION

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

IV Fluids Nursing B23 Objectives Serum Osmolality 275 to 295 Isotonic

Patients and Relatives Perceptions About Intravenous and Subcutaneous Hydration

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.

EZ-IO. Offline Reading Download as PDF. Welcome. Introduction. Anatomy and Physiology. Indications. Paediatric Considerations.

ATI Skills Modules Checklist for Central Venous Access Devices

The Power of Purple* Polyurethane PICC. Patient Guide. Access Systems

Hydration at the End of Life:

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

PREPARATION OF FISTULA NEEDLES TO COMMENCE HAEMODIALYSIS VIA AVF OR GRAFT AND REMOVAL OF NEEDLES AT END OF DIALYSIS SESSION

Vascular access device selection & placement. Alisa Seangleulur, MD Anesthesiology Department, Faculty of Medicine, Thammasat University

Home Intravenous Therapy Team - IV Cannula. An information guide

STEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID

Central Venous Catheter Insertion: Assisting

HOSPITAL INFECTION CONTROL POLICY. Insertion and maintenance of peripheral intravenous cannulae

Understanding your HICKMAN CATHETER

2. Need for serial arterial blood gas determinations. 2. Anticipation of the initiation of thrombolytic therapy

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath

Suboptimal hydration harms patients.

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart

KINGSTON GENERAL HOSPITAL NURSING POLICY AND PROCEDURE

Direct Intravenous (IV) Medication Administration Procedure

Beaumont Hospital Department of Transplantation, Urology and Nephrology. Guideline for administering Intravenous Ferinject in the Renal Unit

Ultrafiltration. A guide for patients undergoing ultrafiltration for the treatment of heart failure

BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST. Clinical Policy for Peripheral Venous Cannula Insertion and Management (Adults)

Value Life Lifecath Midli n e uide to Lifecath Midline rse s G u N A

Acute renal failure in the hospitalised patient: part two

GUIDELINES FOR THE ASSESSMENT AND MANAGEMENT OF MAJOR HAEMORRHAGE IN PALLIATIVE CARE

Insertion of a totally implantable vascular access device (TIVAD)

Urinary catheter passport

Course Syllabus National College of Midwifery /2017

Specialist Palliative Care Audit and Guidelines Group (SPAGG)

Peripheral Intravenous Devices

Intravenous therapy and medication. ELCT Health Department Quality Assurance 2007

A. Complications With Intravenous Catheters FHI B. Central Line Protocol Management of Site Complications C. Intravenous Catheter Complications

Many people use a combination of the standard 17mm cannula and the shorter 13mm cannula length depending where on their body they are inserting.

Deep Vein Thrombosis

Arch Angiography. Exceptional healthcare, personally delivered

MORPHINE ADMINISTRATION

Syringe Drivers. Back to top

Central venous access devices for children with lysosomal storage disorders

INDWELLING SUBCUTANEOUS CATHETER (INSUFLON ) INSERTION, MEDICATION ADMINISTRATION and REMOVAL PURPOSE POLICY STATEMENTS SITE APPLICABILITY

Having a nephrostomy tube inserted

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

Biovalve. A Guide to Peripheral IV Cannulation CANNULATION

SFHCHS20 - SQA Code HD2G 04 Undertake examination of the external ear.

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations

Catheter-directed Thrombolysis

Hypertonic Saline (7%) Administration Guideline (adults)

Use of the Graseby MS26 Syringe Driver For Palliative Care Within West Lothian

Skin Integrity and Wound Care

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS

SARASOTA MEMORIAL HOSPITAL. NURSING PROCEDURE INTRAOSSEOUS NEEDLE: INSERTION, CARE, AND REMOVAL (inv08) 12/18 12/18 1 of 7 RESPONSIBILITY:

Central Venous Access Devices. Stephanie Cunningham Amy Waters

To you who will receive a T-Port PATIENT INFORMATION

ALTERNATIVE TREATMENT

Plastic Surgery Clinic. Skin Grafting. Information

MANITOBA RENAL PROGRAM

MANITOBA RENAL PROGRAM

What is a Leaderflex catheter?

ARROW EZ-IO Intraosseous Vascular Access System Procedure Template

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3

THE CARE AND MAINTENANCE OF TOTALLY IMPLANTED VENOUS ACCESS DEVICES (PORTS)

Patient Information Caring for your Catheter

TYPES AND USES OF VENOUS ACCESS DEVICES

Prof A Pourazar Immunohematologist

Intravenous Catheter Complications

Sacral Nerve Stimulation (SNS) System Implantation

National Occupational Standards

Saline (0.9%) Nebuliser Guideline

Transcription:

NURSING PRACTICE GUIDELINES ADMINISTRATION OF SUBCUTANEOUS FLUIDS INTRODUCTION The infusion of a solution into the subcutaneous tissues is called hypodermoclysis. The subcutaneous compartment (hypodermis) is a layer of loose supporting tissue under the skin. Subcutaneous fluid absorption is possible due to the large number of capillaries ensuring complete and rapid absorption from the site. Hypodermoclysis has a number of advantages compared to the intravenous route. These include: ease of administration, low incidence of infection, little pain or discomfort, no need for prolonged immobilization and minimal medical intervention therefore greater continuity of fluid provision. INDICATIONS The main indication for hypodermoclysis is dehydration. This technique is particularly useful in the elderly. Clinical situations in which hypodermoclysis should be considered for fluid replacement rather than intravenous infusions are: When adequate oral fluid intake is not feasible When there is no acute or specific indication requiring a direct intravenous line i.e. mild to moderate dehydration When the establishment or maintenance of an intravenous line presents problems (Khan & Younger 2007) 1

CONTRA-INDICATIONS Hypodermoclysis should not be used for patients who require more than 2-3 litres of fluid in 24 hours (Hypodermoclysis Working Group 1998; Sasson & Shvartzman 2001; Jackson 2004). It should never be regarded as an alternative to the intravenous route and should not be used to treat: acute life threatening conditions i.e. major dehydration shock diabetic coma (Noble-Adams, 1995) It should be used cautiously in patients with: coagulation defects (Noble-Adams, 1995) possible tissue fibrosis resulting from previous radiotherapy, injury or surgery, since absorption will be decreased Pre-existing heart disease. Subcutaneous fluids (like intravenous fluids) can lead to fluid overload. Care needs to be taken with the volume and rate of the infusion as well as the total sodium load. Pre-existing edema Poor tissue perfusion i.e. Peripheral Vascular Disease HAZARDS The main side effect of hypodermoclysis is subcutaneous edema especially of the gluteal and genital regions (Rafael, Shen & Singer- Edelstein, 1981). 2

SITE CHOICE When choosing a site for infusion factors, to consider include: patient mobility comfort access skin condition Any area with adequate subcutaneous tissue may be used. Potential sites include: abdomen anterior and lateral aspects of chest wall anterior thigh upper arm Scapula (Chan 2001) Areas that should not be used for cannula placement include: Lymphedematous limbs: The rate of absorption would be adversely affected. A break in the skin integrity would increase the risk of infection in a limb that is already susceptible. Over bony prominences: The amount of subcutaneous tissue is diminished therefore impairing the rate of absorption. Previously irradiated skin areas: Radiotherapy can cause sclerosis of small blood vessels, thus reducing skin perfusion. Near a joint: Excessive movement may cause cannula displacement and patient discomfort. Near a surgical or chronic wound site. Sites of infection Areas of inflammation (Sasson & Shvartzman 2001; Dougherty & Lister 2007; RCN 2005) To maximize absorption, rotate the infusion site and document accordingly. Indicators for the need for Rotation are: pain at administration site localized inflammation skin surrounding insertion site becoming white and hard blood is present in giving set/butterfly dislodged needle localized edema bleeding/bruising 3

Best Practice When resiting or restarting an infusion, it is recommended that the site selected is rotated using a figure of eight principle to maximise site absorption. (Brown and Worobec 2000; RCN 2005) TYPE OF INFUSION FLUID The type of infusion fluid administered depends on patient requirements. The solution must be isotonic e.g. 0.9% normal saline or 4% glucose in 0.18% saline. Non electrolyte containing isotonic solutions i.e. 5% glucose should alternate with 0.9% normal saline, as electrolyte free solutions can lead to fluid shift (Khan, Shah & White, 1996). Solutions containing up to 34 mmol potassium/liter fluid may be given however there is a risk of local ulceration with a higher concentration of potassium (Barua & Bhowmick 2005). If irritation occurs at the cannula site, infusion without potassium should be used instead. Best Practice CHOICE OF BUTTERFLY There is evidence to suggest (Dawkins et al; 2000 Braua & Bhowmick 2005) that metal butterfly cannula can be uncomfortable and cause small localized abscesses. Cannula with removable inner metal inserts are favored e.g. Teflon reduces insertion site complications and the need for frequent needle changes. (Ross et al 2002; Centre for Reviews & Dissemination 2005; Khan & Younger 2007) The Product Standardization Group, NUH is currently reviewing products to standardize a device. For further advice contact NUH Palliative care or Pain team Ext.54977. 4

EQUIPMENT LIST Gloves Butterfly cannula (gauge 21or 25) (See Best Practice Box above) Semi-permeable occlusive dressing Choloprep swab Fluid for administration Intravenous infusion giving set Prescription chart See General Principles for All Procedures Best Practice Cleaning the Site Alcohol combined with chlorhexidine is the cleaning agent of choice and the most suitable and practical option (Jackson 2004, RCN 2005) ACTION 1. Site butterfly according to guidelines for Siting a Subcutaneous Infusion Device. Mark on film dressing date and time of insertion. 2. Check the patient details, on the prescription chart, with the patient. Check with the prescription chart that the type of fluid, route and rate is correct (refer to local drug administration policy). 3. Prime the giving set following the procedure for Setting Up an Intravenous Infusion. 4. Attach butterfly cannula to luer end of giving set and regulate the prescribed flow rate and monitor rate of infusion. RATIONALE To ensure butterfly is correctly sited prior to administration of fluid. To facilitate site rotation. To ensure correct fluid is administered to the correct patient. To ensure no air is present in the giving set. To ensure the patient receives the prescribed amount of fluid. 5

Best Practice RATE OF INFUSION The rate of administration is generally less than 125ml/hr provided that the total daily volume does not exceed 2-3 liters in 24 hours. Solutions should be infused by gravity rather than controller as this reduces the chance of local edema formation (Noble-Adams, 1995). Best Practice CARE OF SITE The site should be checked every 4 hours for bruising, reddening, edema, leaking, pain, pooling or unresolved blanching. It is recommended that the insertion site should be rotated after infusion of a maximum of two liters of fluid at a rate of approximately 1ml per minute (Sasson & Shvartzman 2001) The Infection Control Team advise that the giving set should always be changed with each new butterfly insertion. 6

REFERENCES Barua P, Bhowmick BK (2005) Hypoderclysis a victim of historical prejudice. Age and Aging 34, 3, 215-217 Brown MK, Worobec F (2000) Hypodermoclysis another way to replace fluids. Nursing 30, 5, 58-59 Centre for Reviews & Dissemination (2005) A prospective, within-patient comparison between metal butterfly needles & Teflon cannulae in subcutaneous infusion of drugs to terminally ill hospice patients. September, NHS Economic Evaluation Database Chan H (2001) Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin. Journal of Advanced Nursing. 35,6 882-892 7

STANDARD AUDIT POINTS 1. Is there documented evidence of site rotation? 2. Can you identify the date and time of current cannula insertion; is this documented? 3. Was the site condition checked and is there documented evidence of this? 8